Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio (QoQ) (2009 - 2018)
Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio (QoQ) (2009 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -93.87% |
| Dec 31, 2017 | -30.34% |
| Sep 30, 2017 | -85.20% |
| Jun 30, 2017 | 127.19% |
| Mar 31, 2017 | -268.18% |
| Dec 31, 2016 | -619.29% |
| Sep 30, 2016 | -30.30% |
| Jun 30, 2016 | 54.28% |
| Mar 31, 2016 | 20.19% |
| Dec 31, 2015 | -31.77% |
| Sep 30, 2015 | 41.54% |
| Jun 30, 2015 | -11.45% |
| Mar 31, 2015 | 32.43% |
| Dec 31, 2014 | -22.78% |
| Sep 30, 2014 | -30.15% |
| Jun 30, 2014 | -19.69% |
| Mar 31, 2014 | -21.35% |
| Dec 31, 2013 | -55.02% |
| Sep 30, 2013 | 196.43% |
| Jun 30, 2013 | 22.96% |